[HTML][HTML] Severe asthma and biological therapy: when, which, and for whom
P Rogliani, L Calzetta, MG Matera, R Laitano… - Pulmonary therapy, 2020 - Springer
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
Severe Asthma and Biological Therapy: When, Which, and for Whom.
P Rogliani, L Calzetta, MG Matera… - Pulmonary …, 2020 - search.ebscohost.com
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
Severe Asthma and Biological Therapy: When, Which, and for Whom
P Rogliani, L Calzetta, MG Matera, R Laitano… - Pulmonary …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Asthma is a heterogeneous chronic
inflammatory disease of the airways that affects approximately 300 million people …
inflammatory disease of the airways that affects approximately 300 million people …
[PDF][PDF] Severe Asthma and Biological Therapy: When, Which, and for Whom
P Rogliani, L Calzetta, M Matera, R Laitano… - PULMONARY …, 2020 - art.torvergata.it
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
Severe Asthma and Biological Therapy: When, Which, and for Whom
P Rogliani, L Calzetta, MG Matera… - Pulmonary …, 2020 - pubmed.ncbi.nlm.nih.gov
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5-10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5-10% of all asthmatics suffer from …
Severe Asthma and Biological Therapy: When, Which, and for Whom.
P Rogliani, L Calzetta, MG Matera, R Laitano… - Pulmonary …, 2019 - europepmc.org
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
[HTML][HTML] Severe Asthma and Biological Therapy: When, Which, and for Whom
P Rogliani, L Calzetta, MG Matera, R Laitano… - Pulmonary …, 2020 - ncbi.nlm.nih.gov
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5–10% of all asthmatics suffer from …
Severe Asthma and Biological Therapy: When, Which, and for Whom.
P Rogliani, L Calzetta, MG Matera, R Laitano… - Pulmonary …, 2020 - go.gale.com
Asthma is a heterogeneous chronic inflammatory disease of the airways that affects
approximately 300 million people worldwide. About 5-10% of all asthmatics suffer from …
approximately 300 million people worldwide. About 5-10% of all asthmatics suffer from …